▶ 調査レポート

世界の呼吸用使い捨てデバイス市場(~2027):種類別、疾患別、用途別、エンドユーザー別、地域別

• 英文タイトル:Respiratory Disposable Device Market Research Report by Type, Disease Indications, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の呼吸用使い捨てデバイス市場(~2027):種類別、疾患別、用途別、エンドユーザー別、地域別 / Respiratory Disposable Device Market Research Report by Type, Disease Indications, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2304A211資料のイメージです。• レポートコード:MRC2304A211
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、223ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社は、2021年に972.25百万ドルであった世界の呼吸用使い捨てデバイス市場規模が2022年に1,057.67百万ドルに到達し、2027年までにCAGR 8.73%で成長して1,607.32百万ドルへと拡大すると予測しています。当調査資料では、呼吸用使い捨てデバイスの世界市場について多角的な視点から分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別(フェイスマスク、フィルター、吸入器、チューブ)分析、疾患別(喘息、慢性閉塞性肺疾患、肺癌、結核)分析、用途別(成人、小児&新生児)分析、エンドユーザー別(外来診療センター、クリニック、病院、個人)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの項目をまとめました。なお、当書内の企業情報としては、3M Company、Al Maqam Medical Supplies LLC、Ambu A/S、Armstrong Medical Ltd、BAL Supply Inc.、Becton, Dickinson and Company、Bristol Mask、Carolina Diagnostic Solutions LLC、Drive Medical、Fisher & Paykel Healthcare Limitedなどが掲載されています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の呼吸用使い捨てデバイス市場規模:種類別
- フェイスマスクの市場規模
- フィルターの市場規模
- 吸入器の市場規模
- チューブの市場規模
・世界の呼吸用使い捨てデバイス市場規模:疾患別
- 喘息における市場規模
- 慢性閉塞性肺疾患における市場規模
- 肺癌における市場規模
- 結核における市場規模
・世界の呼吸用使い捨てデバイス市場規模:用途別
- 成人における市場規模
- 小児&新生児における市場規模
・世界の呼吸用使い捨てデバイス市場規模:エンドユーザー別
- 外来診療センターにおける市場規模
- クリニックにおける市場規模
- 病院における市場規模
- 個人における市場規模
・世界の呼吸用使い捨てデバイス市場規模:地域別
- 南北アメリカの呼吸用使い捨てデバイス市場規模
アメリカの呼吸用使い捨てデバイス市場規模
カナダの呼吸用使い捨てデバイス市場規模
ブラジルの呼吸用使い捨てデバイス市場規模
...
- アジア太平洋の呼吸用使い捨てデバイス市場規模
日本の呼吸用使い捨てデバイス市場規模
中国の呼吸用使い捨てデバイス市場規模
インドの呼吸用使い捨てデバイス市場規模
韓国の呼吸用使い捨てデバイス市場規模
台湾の呼吸用使い捨てデバイス市場規模
...
- ヨーロッパ/中東/アフリカの呼吸用使い捨てデバイス市場規模
イギリスの呼吸用使い捨てデバイス市場規模
ドイツの呼吸用使い捨てデバイス市場規模
フランスの呼吸用使い捨てデバイス市場規模
ロシアの呼吸用使い捨てデバイス市場規模
...
- その他地域の呼吸用使い捨てデバイス市場規模
・競争状況
・企業情報

The Global Respiratory Disposable Device Market size was estimated at USD 972.25 million in 2021 and expected to reach USD 1,057.67 million in 2022, and is projected to grow at a CAGR 8.73% to reach USD 1,607.32 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Respiratory Disposable Device to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Face Masks, Filters, Inhalers, and Tubes.

Based on Disease Indications, the market was studied across Asthma, Chronic Obstructive Pulmonary Disorder, Lung Cancer, and Tuberculosis.

Based on Application, the market was studied across Adult and Pediatric & Neonatal.

Based on End User, the market was studied across Ambulatory Care Centers, Clinics, Hospitals, and Self-Use.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Respiratory Disposable Device market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Respiratory Disposable Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Disposable Device Market, including 3M Company, Al Maqam Medical Supplies LLC, Ambu A/S, Armstrong Medical Ltd, BAL Supply Inc., Becton, Dickinson and Company, Bristol Mask, Carolina Diagnostic Solutions LLC, Drive Medical, Fisher & Paykel Healthcare Limited, Flexicare Medical Ltd., GS Medical Corp., Hamilton Medical, Hardshell UK, Hovione, Invacare Corporation, Koninklijke Philips N.V., Medline Industries, Inc., Medtronic PLC, Moldex-Metric, Inc., Perlen Converting AG, ResMEd Company, Shawmut Corporation, Smiths Medical Inc. by Smiths Group PLC, Superching Industry Corporation, and Teleflex Incorporated.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Respiratory Disposable Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Disposable Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Disposable Device Market?
4. What is the competitive strategic window for opportunities in the Global Respiratory Disposable Device Market?
5. What are the technology trends and regulatory frameworks in the Global Respiratory Disposable Device Market?
6. What is the market share of the leading vendors in the Global Respiratory Disposable Device Market?
7. What modes and strategic moves are considered suitable for entering the Global Respiratory Disposable Device Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High Prevalence of Respiratory Diseases and Increasing Incidences of Preterm Births
5.1.1.2. Sedentary Lifestyle and Unhealthy Eating Habits
5.1.1.3. Decreasing Air Quality with High Polluted Environment and Growth in Breathing Problems
5.1.2. Restraints
5.1.2.1. Durability and Cost Issues with Disposable Devices
5.1.3. Opportunities
5.1.3.1. Adoption for Online Channel for Sales Boost
5.1.3.2. Rising Government Environmental Concern Regarding Medical Devices
5.1.4. Challenges
5.1.4.1. Limited Healthcare Supply Chain and Awareness About the Product in Low Income Countries
5.2. Cumulative Impact of COVID-19

6. Respiratory Disposable Device Market, by Type
6.1. Introduction
6.2. Face Masks
6.3. Filters
6.4. Inhalers
6.5. Tubes

7. Respiratory Disposable Device Market, by Disease Indications
7.1. Introduction
7.2. Asthma
7.3. Chronic Obstructive Pulmonary Disorder
7.4. Lung Cancer
7.5. Tuberculosis

8. Respiratory Disposable Device Market, by Application
8.1. Introduction
8.2. Adult
8.3. Pediatric & Neonatal

9. Respiratory Disposable Device Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.3. Clinics
9.4. Hospitals
9.5. Self-Use

10. Americas Respiratory Disposable Device Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Respiratory Disposable Device Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Respiratory Disposable Device Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. 3M Company
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Al Maqam Medical Supplies LLC
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Ambu A/S
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Armstrong Medical Ltd
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BAL Supply Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Becton, Dickinson and Company
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Bristol Mask
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Carolina Diagnostic Solutions LLC
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Drive Medical
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Fisher & Paykel Healthcare Limited
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Flexicare Medical Ltd.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. GS Medical Corp.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Hamilton Medical
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Hardshell UK
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Hovione
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Invacare Corporation
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Koninklijke Philips N.V.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Medline Industries, Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Medtronic PLC
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Moldex-Metric, Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Perlen Converting AG
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. ResMEd Company
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Shawmut Corporation
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Smiths Medical Inc. by Smiths Group PLC
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Superching Industry Corporation
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
14.26. Teleflex Incorporated
14.26.1. Business Overview
14.26.2. Key Executives
14.26.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing